MedPath

Laser Acupuncture for Idiopathic Bell's Palsy

Not Applicable
Recruiting
Conditions
Bell Palsy
Interventions
Device: Laser acupuncture
Drug: Steroids
Device: Sham laser acupuncture
Registration Number
NCT06732622
Lead Sponsor
Beijing Tongren Hospital
Brief Summary

Bell's palsy is characterized by acute, unilateral onset that compromises function and esthetics, exerting a considerable impact on the social, professional, and psychological aspects of the lives of affected individuals. The objective of this study was to determine whether laser acupuncture therapy could relieve symptoms in patients with Bell's palsy.

Detailed Description

This study was randomized controlled trial including 360 patients that undergoing Bell's palsy. All the patients received oral Prednisolone. Patients were assigned to the laser acupuncture (LA) group, Sham LA group and control group, with 120 patients in each group. LA group and Sham LA group were received 4 weeks of Laser treatment (3 times per week).

Clinical outcome measure comprised the House-Brackmann grading system, Sunnybrook facial grading scale (SBFG), Facial Disability Index (FDI) and Facial Clinimetric Evaluation Scale (FaCE Scale) All the measurements were collected at the baseline, weeks 2, 4, 6, 8, 12 and 24.

Recruitment & Eligibility

Status
RECRUITING
Sex
All
Target Recruitment
360
Inclusion Criteria
    1. Patients diagnosed with idiopathic Bell's Palsy 2.Patients were eligible if they were graded at House-Brackmann grade (HB) 3 or higher.
Exclusion Criteria
    1. Serious mental illness or social problems, and neurological disorders, and systemic diseases, such as malignant tumors, and other serious consumptive diseases. 2. Planning for pregnancy, those in pregnancy, or those who were lactating. 3.Bell's Palsy patients who have a disease course of more than 8 weeks.

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Laser acupuncture GroupLaser acupuncture-
Laser acupuncture GroupSteroids-
Sham laser acupuncture GroupSteroids-
Sham laser acupuncture GroupSham laser acupuncture-
Control groupSteroids-
Primary Outcome Measures
NameTimeMethod
House Brackmann Grading System (HB)Baseline, weeks 2, 4, 6, 8, 12 and 24

The HB is a physician-rated system based on criteria of resting appearance, facial movements, and synkinesis that categorizes facial function from I (normal) to VI (total paralysis), with options of "Normal", "Mild dysfunction", "Moderate dysfunction", "Moderately severe dysfunction", "Severe dysfunction" or "Total paralysis". The prognoses of grade 3 or higher were abnormal.

Secondary Outcome Measures
NameTimeMethod
Sunnybrook Facial Grading Scale (SB Grading)Baseline, weeks 2, 4, 6, 8, 12 and 24

The Sunnybrook Facial Grading Scale was used because of its international recognition and because it allowed a separate classification of the degree of synkinesis. The SB Grading is divided into three subscales of resting symmetry (Eye and Mouth range from 0 to 1, Cheek ranges from 0 to 2), symmetry of voluntary movement (ranges from 1 to 5), and synkinesis (ranges from 0 to 3). The three subscores are used to calculate a composite score (ranges from 0 to 100).

Facial Disability Index (FDI)Baseline, weeks 2, 4, 6, 8, 12 and 24

Facial Disability Index (FDI) is a brief, self-report questionnaire of physical disability and psychosocial factors related to facial neuromuscular function. The FDI is a 10-item test that is divided into physical function (ranges from 0 to 5). and social/ well-being function (ranges from 1 to 6) domains. The physical function scores range from -25 (worst) to 100 (best), and the social/wellbeing function scores range from 0 (worst) to 100 (best).

Facial Clinimetric Evaluation Scale (FaCE Scale)Baseline, weeks 2, 4, 6, 8, 12 and 24

FaCE is 15-items, self-reported questionnaire that used to assess facial impairment and disability after facial paralysis.

It includes six independent domains: social function, facial movement, facial comfort, oral function, eye comfort, and lacrimal control. the total scores range from 0 (worst) to 100 (best).

Trial Locations

Locations (1)

China Beijing TongRen Hospital, Capital Medical University Beijing, China

🇨🇳

Beijing, Beijing, China

© Copyright 2025. All Rights Reserved by MedPath